title: An individualized left ventricular lead-targeting strategy improves long-term survival of cardiac resynchronization therapy patients and influences the benefit of the implantable cardioverter-defibrillator: a long-term follow-up of the TARGET study.
authors.affiliation: aCardiology Department, Papworth Hospital NHS Foundation Trust bDepartment of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge cCardiology Department, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: Sergio
authors.initials: S
authors.lastname: Barra
authors.forename: Emma
authors.initials: E
authors.lastname: Yu
authors.forename: Fakhar
authors.initials: F
authors.lastname: Khan
authors.forename: David
authors.initials: D
authors.lastname: Dutka
authors.forename: Munmohan
authors.initials: M
authors.lastname: Virdee
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D058406:Cardiac Resynchronization Therapy / Q000009:adverse effects / Q000401:mortality; D058409:Cardiac Resynchronization Therapy Devices; D000066491:Clinical Decision-Making; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000009:adverse effects / Q000295:instrumentation* / Q000401:mortality; D005260:Female; D006333:Heart Failure / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D011474:Prosthesis Design; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D016277:Ventricular Function, Left